Skip to main content

Table 1 General characteristics of the study population according to the diagnosis of pancreatic cancer

From: Healthcare vulnerability disparities in pancreatic cancer treatment and mortality using the Korean National Sample Cohort: a retrospective cohort study

Variables

Total

3-month mortality

P-value

6-month mortality

P-value

1-year Mortality

P-value

No

Yes

No

Yes

No

Yes

Total

1,975

(100.0)

1,498

(75.8)

477

(24.2)

 

1,191

(60.3)

784

(39.7)

 

836

(42.3)

1,139

(57.7)

 

Healthcare Vulnerability

      

 < .0001

    

0.0003

    

0.0180

 Vulnerable region

279

(14.1)

184

(65.9)

95

(34.1)

 

141

(50.5)

138

(49.5)

 

100

(35.8)

179

(64.2)

 

 Non-vulnerable region

1,696

(85.9)

1,314

(77.5)

382

(22.5)

 

1,050

(61.9)

646

(38.1)

 

736

(43.4)

960

(56.6)

 

Pancreatic Cancer Treatment

      

 < .0001

    

 < .0001

    

 < .0001

 Yes

860

(43.5)

795

(92.4)

65

(7.6)

 

676

(78.6)

184

(21.4)

 

455

(52.9)

405

(47.1)

 

 No

1,115

(56.5)

703

(63.0)

412

(37.0)

 

515

(46.2)

600

(53.8)

 

381

(34.2)

734

(65.8)

 

Sex

      

0.3964

    

0.7728

    

0.5420

 Male

1,093

(55.3)

821

(75.1)

272

(24.9)

 

656

(60.0)

437

(40.0)

 

456

(41.7)

637

(58.3)

 

 Female

882

(44.7)

677

(76.8)

205

(23.2)

 

535

(60.7)

347

(39.3)

 

380

(43.1)

502

(56.9)

 

Age

      

 < .0001

    

 < .0001

    

 < .0001

  < 50

173

(8.8)

157

(90.8)

16

(9.2)

 

138

(79.8)

35

(20.2)

 

122

(70.5)

51

(29.5)

 

 50–60

311

(15.7)

275

(88.4)

36

(11.6)

 

234

(75.2)

77

(24.8)

 

163

(52.4)

148

(47.6)

 

 60–70

503

(25.5)

415

(82.5)

88

(17.5)

 

350

(69.6)

153

(30.4)

 

251

(49.9)

252

(50.1)

 

 70–80

598

(30.3)

431

(72.1)

167

(27.9)

 

320

(53.5)

278

(46.5)

 

217

(36.3)

381

(63.7)

 

  > 80

390

(19.7)

220

(56.4)

170

(43.6)

 

149

(38.2)

241

(61.8)

 

83

(21.3)

307

(78.7)

 

Household income

      

0.7841

    

0.3680

    

0.2443

 Low

437

(22.1)

326

(74.6)

111

(25.4)

 

251

(57.4)

186

(42.6)

 

171

(39.1)

266

(60.9)

 

 Mid-low

621

(31.4)

474

(76.3)

147

(23.7)

 

377

(60.7)

244

(39.3)

 

275

(44.3)

346

(55.7)

 

 Mid-high

917

(46.4)

698

(76.1)

219

(23.9)

 

563

(61.4)

354

(38.6)

 

390

(42.5)

527

(57.5)

 

Medical Insurance

      

0.8633

    

0.5623

    

0.2294

 Insurance Coverage (Regional)

639

(32.4)

480

(75.1)

159

(24.9)

 

381

(59.6)

258

(40.4)

 

262

(41.0)

377

(59.0)

 

 Insurance Coverage (corporate)

1,279

(64.8)

975

(76.2)

304

(23.8)

 

779

(60.9)

500

(39.1)

 

555

(43.4)

724

(56.6)

 

 Medical Aid

57

(2.9)

43

(75.4)

14

(24.6)

 

31

(54.4)

26

(45.6)

 

19

(33.3)

38

(66.7)

 

Disorder

      

0.0355

    

0.0168

    

0.0339

 No

1,828

(92.6)

1,397

(76.4)

431

(23.6)

 

1,116

(61.1)

712

(38.9)

 

786

(43.0)

1,042

(57.0)

 

 Yes

147

(7.4)

101

(68.7)

46

(31.3)

 

75

(51.0)

72

(49.0)

 

50

(34.0)

97

(66.0)

 

CCI

      

0.0003

    

0.0269

    

0.8036

 0

353

(17.9)

262

(74.2)

91

(25.8)

 

211

(59.8)

142

(40.2)

 

145

(41.1)

208

(58.9)

 

 1–2

885

(44.8)

708

(80.0)

177

(20.0)

 

561

(63.4)

324

(36.6)

 

381

(43.1)

504

(56.9)

 

  ≥ 3

737

(37.3)

528

(71.6)

209

(28.4)

 

419

(56.9)

318

(43.1)

 

310

(42.1)

427

(57.9)

 
  1. CCI Charlson Comorbidity Index